doctor on phone-Referrals for Clinicians

How We Work With Therapists & Healthcare Providers

In our experience, patients are best served when the all members of the provider team work together and are fully informed. We value your expertise and welcome the opportunity to support you and your patients.

We Work With:

  • Psychiatrists
  • Therapists
  • Psychologists
  • Neurologists
  • Pain Specialists
  • Primary Care Physicians
  • Coaches
  • Social Workers

Treatments for:

  • Depression
  • Anxiety
  • PTSD
  • Migraines & Headaches
  • CRPS & Chronic Pain
  • Immunity & Resilience

Our Services:

  • IV Ketamine
  • IV NAD+
  • IV Nutrients & Vitamins
  • Intranasal Ketamine & NAD+
  • IV Glutathione
  • Ketamine Assisted Psychotherapy (KAP)

Refer Your Patient To Us

If you are a doctor or therapist with a patient you think could benefit from Combination Infusion Therapy, then please submit our referral form.

  • Submit Your Patient Referral Form

Let us help you support your patients!

We pride ourselves on offering our patients a process that is administratively efficient and clinically rigorous while maintining a high level of personalized care and attention.

Step 1: Confirm Your Patient's Interest

The first step is to confirm your patient's openness/interest in infusion therapies such as Ketamine, NAD+, Vitamins, Glutathione, etc. by having a conversation with the differences between Combination Infusion Therapy and conventional approaches to treating anxiety, depression and PTSD.

Step 2: Submit Online Patient Referral Form

If you believe your patient may be a good fit for guided Ketamine treatments, then please tell us a little about them so we may contact them. You can submit a Patient Referral Form here.

Step 3: Review Patient Care Plan With Us

Once we have spoken with your patient and received required documents, we will contact you to confirm/discuss our treatment plan. We value your input and experience and will work closely with you to ensure the best patient care possible.

Step 4: We Provide Ongoing Updates About Treatments and Progress

With your patient's consent, we will share treatment information with you in order to keep you informed of their progress.

Latest Science & Research

ketamine-for-depression-a-clinical-summary.png-Ketamine for Depression, A Clinical Summary

Ketamine for Depression, A Clinical Summary

June 24, 2022

Chittaranjan Andrade 11 Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India. Chittaranjan …

Ketamine for Depression, A Clinical Summary Read More »

Read More
how-the-glutathione-cycle-shapes-synaptic-glutamate-activity.png-How the glutathione cycle shapes synaptic glutamate activity

How the glutathione cycle shapes synaptic glutamate activity

June 7, 2022

    Thomas W Sedlak 1, Bindu D Paul 2, Gregory M Parker 3, Lynda D Hester 2, Adele M Snowman 2, Yu Taniguchi 3, Atsushi Kamiya 3, Solomon …

How the glutathione cycle shapes synaptic glutamate activity Read More »

Read More
nejm1-1-Trial of Psilocybin versus Escitalopram for Depression

Trial of Psilocybin versus Escitalopram for Depression

April 15, 2021

Psilocybin may have antidepressant properties, but direct comparisons between psilocybin and established treatments for depression are lacking.

Read More
intranasal-Comparative Efficacy of Racemic Ketamine and Esketamine for Depression

Comparative Efficacy of Racemic Ketamine and Esketamine for Depression

February 15, 2021

Intravenous ketamine appears to be more efficacious than intranasal esketamine for the treatment of depression.

Read More
Scroll to Top